iomics Bio Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 7

iomics Bio General Information

Description

Developer and provider of life sciences technologies and clinical medicine designed for human health. The company combines microfluidics and AI, blockchain, big data analysis and other technologies to develop and industrialize a series of highly sensitive automated molecular detection systems and supporting reagents, providing in-depth insights into the analysis of cell groups, proteomes, metabolomes, genomes and other health information, providing users with innovative technology products and services for the whole process of prevention of diseases, precise diagnosis, individualized treatment and drug development.

Contact Information

Website
www.iomicsbio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 401/503, Building 19, Lanbei Technology Park, Houshayu
  • Shunyi District
  • Beijing, 100102
  • China
+86 010
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Drug Discovery
Vertical(s)
Big Data, Life Sciences
Corporate Office
  • Room 401/503, Building 19, Lanbei Technology Park, Houshayu
  • Shunyi District
  • Beijing, 100102
  • China
+86 010

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

iomics Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 06-Mar-2024 Completed Generating Revenue
3. Early Stage VC (Series A1) 03-Apr-2023 Completed Generating Revenue
2. Early Stage VC (Series A) 20-Jun-2022 $14.9M $22.5M Completed Generating Revenue
1. Early Stage VC 15-Dec-2020 $7.61M $7.61M Completed Generating Revenue
To view iomics Bio’s complete valuation and funding history, request access »

iomics Bio Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Xiamen Wangchen Investment Corporate Venture Capital Minority
Beijing Chaoyang International Technology Innovation Service Government Minority
Tsingyuan Defeng Venture Capital Minority
Yuanhui Investment Growth/Expansion Minority
Apricot Capital (Shanghai) Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial

iomics Bio FAQs

  • When was iomics Bio founded?

    iomics Bio was founded in 2019.

  • Where is iomics Bio headquartered?

    iomics Bio is headquartered in Beijing, China.

  • What industry is iomics Bio in?

    iomics Bio’s primary industry is Diagnostic Equipment.

  • Is iomics Bio a private or public company?

    iomics Bio is a Private company.

  • What is iomics Bio’s current revenue?

    The current revenue for iomics Bio is .

  • How much funding has iomics Bio raised over time?

    iomics Bio has raised $22.5M.

  • Who are iomics Bio’s investors?

    Xiamen Wangchen Investment, Beijing Chaoyang International Technology Innovation Service, Tsingyuan Defeng, Yuanhui Investment, and Apricot Capital (Shanghai) are 5 of 7 investors who have invested in iomics Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process